Chemfar Limited - Period Ending 2017-12-31

Chemfar Limited - Period Ending 2017-12-31


Chemfar Limited 08319535 false 2017-01-01 2017-12-31 2017-12-31 The principal activity of the company is dealing in active pharmaceutical ingredients. Digita Accounts Production Advanced 6.20.8420.0 Software true 08319535 2017-01-01 2017-12-31 08319535 2017-12-31 08319535 bus:OrdinaryShareClass1 2017-12-31 08319535 core:RetainedEarningsAccumulatedLosses 2017-12-31 08319535 core:ShareCapital 2017-12-31 08319535 core:CurrentFinancialInstruments core:WithinOneYear 2017-12-31 08319535 core:Non-currentFinancialInstruments core:AfterOneYear 2017-12-31 08319535 bus:SmallEntities 2017-01-01 2017-12-31 08319535 bus:AuditExemptWithAccountantsReport 2017-01-01 2017-12-31 08319535 bus:AbridgedAccounts 2017-01-01 2017-12-31 08319535 bus:RegisteredOffice 2017-01-01 2017-12-31 08319535 bus:Director1 2017-01-01 2017-12-31 08319535 bus:OrdinaryShareClass1 2017-01-01 2017-12-31 08319535 bus:PrivateLimitedCompanyLtd 2017-01-01 2017-12-31 08319535 bus:Agent1 2017-01-01 2017-12-31 08319535 countries:AllCountries 2017-01-01 2017-12-31 08319535 2016-12-31 08319535 bus:OrdinaryShareClass1 2016-12-31 08319535 core:RetainedEarningsAccumulatedLosses 2016-12-31 08319535 core:ShareCapital 2016-12-31 08319535 core:CurrentFinancialInstruments core:WithinOneYear 2016-12-31 08319535 core:Non-currentFinancialInstruments core:AfterOneYear 2016-12-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 08319535

Chemfar Limited



Annual Report and Unaudited Abridged Financial Statements

for the Year Ended 31 December 2017

Gower Accountancy Limited
Chartered Certified Accountants
Second Floor
4-5 Gough Square
London
EC4A 3DE

 

Chemfar Limited

Contents

Company Information

1

Director's Report

2

Accountants' Report

3

Abridged Balance Sheet

4

Notes to the Abridged Financial Statements

5 to 7

 

Chemfar Limited

Company Information

Director

Mr D Gatecha

Registered office

250 Humberstone Road
Leicester
Leicestershire
LE5 0EG

Accountants

Gower Accountancy Limited
Chartered Certified Accountants
Second Floor
4-5 Gough Square
London
EC4A 3DE

 

Chemfar Limited

Director's Report for the Year Ended 31 December 2017

The director presents his report and the abridged financial statements for the year ended 31 December 2017.

Director of the company

The director who held office during the year was as follows:

Mr D Gatecha

Principal activity

The principal activity of the company is dealing in active pharmaceutical ingredients.

Small companies provision statement

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved by the director on 24 April 2018 and signed on its behalf by:

.........................................
Mr D Gatecha
Director

 

Chartered Certified Accountants' Report to the Director on the Preparation of the Unaudited Statutory Accounts of
Chemfar Limited
for the Year Ended 31 December 2017

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Chemfar Limited for the year ended 31 December 2017 as set out on pages 4 to 7 from the company's accounting records and from information and explanations you have given us.

It is your duty to ensure that Chemfar Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Chemfar Limited. You consider that Chemfar Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of Chemfar Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................

Gower Accountancy Limited
Chartered Certified Accountants
Second Floor
4-5 Gough Square
London
EC4A 3DE

24 April 2018

 

Chemfar Limited

(Registration number: 08319535)
Abridged Balance Sheet as at 31 December 2017

Note

2017
£

2016
£

Current assets

 

Stocks

3

15,465

15,465

Debtors

548,167

60,376

Cash at bank and in hand

 

74,528

21,259

 

638,160

97,100

Creditors: Amounts falling due within one year

(121,225)

(34,642)

Total assets less current liabilities

 

516,935

62,458

Creditors: Amounts falling due after more than one year

(32,161)

(32,161)

Accruals and deferred income

 

(429,162)

-

Net assets

 

55,612

30,297

Capital and reserves

 

Called up share capital

100

100

Profit and loss account

55,512

30,197

Total equity

 

55,612

30,297

For the financial year ending 31 December 2017 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the director on 24 April 2018
 

.........................................

Mr D Gatecha

Director

 

Chemfar Limited

Notes to the Abridged Financial Statements for the Year Ended 31 December 2017

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
250 Humberstone Road
Leicester
Leicestershire
LE5 0EG
United Kingdom

These financial statements were approved by the director on 24 April 2018.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

Chemfar Limited

Notes to the Abridged Financial Statements for the Year Ended 31 December 2017

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the Profit and Loss Account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Stocks

2017
£

2016
£

Other inventories

15,465

15,465

 

Chemfar Limited

Notes to the Abridged Financial Statements for the Year Ended 31 December 2017

4

Share capital

Allotted, called up and fully paid shares

 

2017

2016

 

No.

£

No.

£

Ordinary shares of £1 each

100

100

100

100